IL32 prompts cell activation and cancer-related pathways. IL32 prompts cell activation and cancer-related pathways. Venn diagram reveals the numbers of upregulated (red) and downregulated (blue) probe sets in IL32-treated MyLa cells and/or HH cells. Significantly upregulated canonical pathways (P < 0.05) and selected canonical pathways (with P values close to 0.05) in IL32-treated MyLa cells and/or HH cells are shown with P values. Hanako Ohmatsu et al. Cancer Immunol Res 2014;2:890-900 ©2014 by American Association for Cancer Research